Geldanamycin or its analogs have been shown to radiosensitize in vitro an array of cancer cell lines from many tissue origins [9], [11]–[14], [16], [18], proving the broad therapeutic applicability of HSP90 inhibitors as radiosensitizers. Here, HSP90AA1 is linked to cancer.